beta-lysylmethanediamine has been researched along with Malaria in 1 studies
*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishiyama, A; Iwatsuki, M; Kondo, S; Namatame, M; Nishihara-Tukashima, A; Omura, S; Otoguro, K; Shibahara, S; Yamada, H | 1 |
1 other study(ies) available for beta-lysylmethanediamine and Malaria
Article | Year |
---|---|
Promising lead compounds for novel antiprotozoals.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimalarials; Antiprotozoal Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Lysine; Malaria; Pactamycin; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |